Action Matinas Biopharma - MTNB

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

0,518

Prix Achat

Prix Vente

Volume échangé

35 900

0,51 Fourchette du Jour 0,525

0,50 Plage de 52 semaines 21,50

Cap du marché

2,635M

Clôture Veille

0,53

Ouverture

0,51

Dernière Transaction

0.5171

Dernière heure de transaction

18:11:50

Volume financier

US$ 18 573

VWAP

0,517345

Volume moyen (3 m)

233 481

Actions en circulation

5 086 985

Rendement du Dividende

Ratio Cours sur Bénéfices

-0,11

Bénéfice par action (BPA)

-4,51

Chiffre d'affairess

1,1M

Bénéfice net

-22,94M

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others. Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of product candidates derived from its lipid-crystal nano-particle, or cochleate, delivery technology platform. The firm's pipeline includes MAT2203, MAT2501 and others.

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.matinasbiopharma.com

Siège social

Wilmington, Delaware, USA

Fondé

Matinas Biopharma Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la American Stock Exchange avec le ticker MTNB. Le dernier cours de clôture d'Matinas Biopharma était de US$0,53. Au cours de la dernière année, les actions de Matinas Biopharma ont été négociées dans une fourchette de prix de US$ 0,50 à US$ 21,50.

Matinas Biopharma compte actuellement 5 086 985 actions en circulation. La capitalisation boursière d'Matinas Biopharma est de US$2,70 million. Matinas Biopharma a un ratio cours/bénéfice (ratio PE) de -0.11.

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction

BEDMINSTER, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) announces that negotiations under the previously disclosed non-binding term sheet...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.059	-10.2253032929	0.577	0.5923	0.51	52347	0.53707444	CS
4	-0.142	-21.5151515152	0.66	0.665	0.51	78487	0.57612373	CS
12	-2.582	-83.2903225806	3.1	4.25	0.5	233481	0.83581207	CS
26	-7.462	-93.5087719298	7.98	9.6	0.5	560286	5.7450334	CS
52	-9.557	-94.858560794	10.075	21.5	0.5	926219	9.78935275	CS
156	-51.482	-99.0038461538	52	53	0.5	1374411	22.30086852	CS
260	-87.982	-99.4146892655	88.5	124.5	0.5	1828047	40.74905114	CS

MTNB - Frequently Asked Questions (FAQ)

What is the current Matinas Biopharma share price?

The current share price of Matinas Biopharma is US$ 0,518

How many Matinas Biopharma shares are in issue?

Matinas Biopharma has 5 086 985 shares in issue

What is the market cap of Matinas Biopharma?

The market capitalisation of Matinas Biopharma is USD 2,7M

What is the 1 year trading range for Matinas Biopharma share price?

Matinas Biopharma has traded in the range of US$ 0,50 to US$ 21,50 during the past year

What is the PE ratio of Matinas Biopharma?

The price to earnings ratio of Matinas Biopharma is -0,11

What is the cash to sales ratio of Matinas Biopharma?

The cash to sales ratio of Matinas Biopharma is 2,37

What is the reporting currency for Matinas Biopharma?

Matinas Biopharma reports financial results in USD

What is the latest annual turnover for Matinas Biopharma?

The latest annual turnover of Matinas Biopharma is USD 1,1M

What is the latest annual profit for Matinas Biopharma?

The latest annual profit of Matinas Biopharma is USD -22,94M

What is the registered address of Matinas Biopharma?

The registered address for Matinas Biopharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Matinas Biopharma website address?

The website address for Matinas Biopharma is www.matinasbiopharma.com

Which industry sector does Matinas Biopharma operate in?

Matinas Biopharma operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
CTMCastellum Inc	US$ 1,01 (74,14%)	27,1M
RYDERyde Group Ltd	US$ 0,41 (32,26%)	20,29M
OPTTOcean Power Technologies Inc	US$ 0,4235 (28,84%)	46,16M
ITPIT Tech Packaging Inc	US$ 0,282 (28,18%)	2,57M
KULRKULR Technology Group Inc	US$ 4,245 (24,12%)	76,55M
BTOPBitwise Trendwise BTC ETH and Treasuries Rotation Strategy ETF	US$ 35,04 (-38,06%)	3,19k
BITCBitwise Trendwise Bitcoin and Treasuries Rotation Strategy ETF	US$ 47,4487 (-29,87%)	13,41k
AETHBitwise Trendwise Ether and Treasuries Rotation Strategy ETF	US$ 37,05 (-12,78%)	2,98k
TOVXTheriva Biologics Inc	US$ 1,588 (-9,77%)	667k
ETHU2x Ether ETF	US$ 7,86 (-9,71%)	13,65M
KULRKULR Technology Group Inc	US$ 4,2452 (24,13%)	76,82M
OPTTOcean Power Technologies Inc	US$ 0,4105 (24,89%)	47,15M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 1,9789 (-0,31%)	36,31M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 31,015 (1,76%)	29,06M
CTMCastellum Inc	US$ 0,9885 (70,43%)	27,7M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Matinas Biopharma Holdings Inc (MTNB) Cours

Matinas Biopharma Holdings Inc (MTNB)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

À propos de Matinas Biopharma Holdings Inc

MTNB Dernières nouvelles

MTNB - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application